Sign in

CIK 0001802665

  • Large accelerated filer

Harmony Biosciences Holdings, Inc.

Sign in to watch
Ticker
HRMY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
822279923
Phone
+1 484-539-9800
Business address
630 W GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING, PA, 19462
  1. 4 Open-market sale President, CEO sold 15,000 shares at an average $45.42 ($681,277)
  2. 4 Open-market sale President, CEO sold 25,000 shares at an average $44.18 ($1,104,411)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market sale Director sold 6,554 shares at $52.19 ($342,053)
  10. 4 Open-market sale Director sold 132,258 shares at an average $52.30 ($6,916,488)
  11. 4 Open-market sale Director sold 119,829 shares at an average $51.07 ($6,120,014)
  12. 4 Open-market sale Director sold 11,165 shares at an average $50.17 ($560,097)
  13. 4 Open-market sale Director sold 21,394 shares at an average $50.24 ($1,074,792)
  14. 4 Open-market sale Chief Commercial Officer sold 14,471 shares at an average $49.63 ($718,170)
  15. 4 Open-market sale Director sold 37,391 shares at an average $50.21 ($1,877,309)
  16. 4 Open-market sale Director sold 114,121 shares at an average $50.66 ($5,781,098)
  17. 4 Derivatives Options or other derivatives
  18. 4 Open-market sale Director sold 36,294 shares at an average $50.16 ($1,820,523)
  19. 4 Open-market sale Director sold 16,181 shares at an average $50.08 ($810,373)
  20. 4 Open-market sale President, CEO sold 15,000 shares at $45.32 ($679,821)

Page 7 of 11 · 213 filings